[1] |
Lumbiganon P, Laopaiboon M, Gülmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08[J]. Lancet, 2010,375:490-499.
|
[2] |
Betran AP, Ye J, Moller AB, et al. Trends and projec-tions of caesarean section rates: global and regional estimates[J]. BMJ Glob Health, 2021,6:e005671.doi:10.1136/bmjgh-2021-005671.
|
[3] |
Mhyre JM, Sultan P. General anesthesia for cesarean delivery: occasionally essential but best avoided[J]. Anesthesiology, 2019,130:864-866.
|
[4] |
Liu M, Wang B, Prudence B, et al. Effect of different doses of epidural dexmedetomidine on reducing visceral traction reaction for cesarean section: a double-blind randomized controlled trial[J]. J Anesth, 2023,37:371-378.
|
[5] |
雷敏,王力甚.剖宫产术中牵拉反应预防与治疗的研究进展[J].临床医学研究与实践,2021,6:193-195.
|
[6] |
McCombe K, Bogod DG. Learning from the law. a review of 21 years of litigation for pain during caesarean section[J]. Anaesthesia,2018,73:223-230.
|
[7] |
Landau R, Janvier AS. Are we finally tackling the issue of pain during cesarean section?[J]. Anaesth Crit Care Pain Med, 2021,40:100938.doi:10.1016/j.accpm.2021.100938.
|
[8] |
Bollag L, Lim G, Sultan P, et al. Society for obstetric anesthesia and perinatology: consensus statement and recommendations for enhanced recovery after cesarean[J]. Anesth Analg, 2021,132:1362-1377.
|
[9] |
Watson SE, Richardson AL, Lucas DN. Neuraxial and general anaesthesia for caesarean section[J]. Best Pract Res Clin Anaesthesiol, 2022,36:53-68.
|
[10] |
Hong JY, Jee YS, Jeong HJ,et al. Effects of epidural fentanyl on speed and quality of block for emergency cesarean section in extending continuous epidural labor analgesia using ropivacaine and fentanyl[J]. J Korean Med Sci, 2010,25:287-292.
|
[11] |
Rivière PJ. Peripheral kappa-opioid agonists for visceral pain[J]. Br J Pharmacol, 2004,141:1331-1334.
|
[12] |
An Y, Zhao L, Wang T, et al. Preemptive oxycodone is superior to equal dose of sufentanil to reduce visceral pain and inflammatory markers after surgery: a randomized controlled trail[J]. BMC Anesthesiol, 2019,19:96.doi.org/10.1186/s12871-019-0775-x.
|
[13] |
Arendt-Nielsen L, Olesen AE, Staahl C, et al. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain[J]. Anesthesiology, 2009,111:616-624.
|
[14] |
Kopruszinski CM, Watanabe M, Martinez AL, et al. Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic priming[J]. Pain, 2023,164:e263-e273.
|
[15] |
Seaton S, Reeves M, McLean S. Oxycodone as a component of multimodal analgesia for lactating mothers after caesarean section: relationships between maternal plasma, breast milk and neonatal plasma levels[J]. Aust N Z J Obstet Gynaecol,2007,47:181-185.
|